Nested
Member
For those who have tried both Cagrilintide and Semaglutide. If you had to pick just one, which would you say is better for fat loss and overall results?
Last edited:
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
holy shit thats a lot of sema
I was thinking the combination of GLP1s and Metformin might be interesting, since Metformin was found to agonize the Leptin receptors in the brain, providing a different pathway for appetite suppressionThat's what I thought but for those who made it to 2.4mg of Sema using the normal titration, going up to 7.2mg didn't increase sides very much. Didn't increase weight loss very much either, increasing from 16% to 21% of body weight.
There are only so many GLP receptors, and once they're saturated, there's no more effect from Sema no matter how large the dose.
The theory explaining different levels of response between individuals is that weight loss is determined by the percentage of total receptors agonized by GLP-1. Those with low receptor density respond more strongly to lower doses. The genetic tests that predict GLP response use receptor density genes as a marker to predict good vs poor responders. People with poor GLP response becaue they have a very high density of receptors are also much more likely to be or become obese.
I was thinking the combination of GLP1s and Metformin might be interesting, since Metformin was found to agonize the Leptin receptors in the brain, providing a different pathway for appetite suppression
Metformin has been a part of the anti-aging ethos for a decade at like 500mg QD
Once again Big Pharma strikes. The average "entrepeneur" hustler peddling shit content on social media only wishes they had half the "make money at all costs" drive that those people have lolLooks like Sema doses up to 7.2mg are going to hit the market later this year.
Caremark, the 2nd largest pharmacy benefits manager service in the US, covering meds for 103 million patients in the US recently announced they're dropping Zepbound (Tirz) coverage and transitioning those patients to Wegovy (Sema).
That's huge (in a shit way for patients) but a clear indicator Novo Nordisk has decided to offer Sema as the cheaper alternative to Tirz, and going to max doses of 7.2mg for Sema significantly closes the gap between the two.
Still, a lot of metabolic benefits are lost vs Tirz, and a terrible development for future patients with Caremark.
This also brings into question just how willing insurance will be to cover newer, presumably more expensive GLPs like Reta or CagriSema, if they're willing to boot millions of people off Zepbound (which had dropped significantly in price already).
*I say "future" because existing patients with a sharp doctor may be able to fight to keep them on Zepbound, especially if they're on maintenance doses of 12.5mg+ which 7.2mg Sema can't match in terms of weight loss.
